Expected Moves

Market reassessment of Chemring's order intake and potential delays in UK Government defense spending prior to the fiscal year-end. Evaluates $7.94 base against $8.60 target and $7.01 fallback.

Release of FY2026 earnings, focusing on the conversion of the £1.4B record order book, free cash flow recovery, and margin defense amid energetics capacity expansion.

First-quarter trading update to validate the ramp-up of the Scottish and Norwegian energetics facilities and confirm FY2027 guidance.

Release of H1 2027 financial results, detailing segment profitability in Countermeasures & Energetics vs. Sensors & Information.